Contact HealthDay
Tel: 203.855.1400 or E-mail

News By Specialty

Allergy
Anesthesiology
Cardiology
Cosmetic Surgery
Critical Care
Dermatology
Diabetes & Endocrinology
Emergency Medicine
Family Practice
Gastroenterology
Geriatrics
Hematology & Oncology
HIV & AIDS
Infectious Disease
Internal Medicine
Nephrology
Neurology
Nursing
OBGYN & Women's Health
Ophthalmology
Orthopedics
Otolaryngology
Pain Management
Pathology
Pediatrics
Pharmacy
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology

Follow us on:

    


e-Healthcare Leadership Awards


Three-Year Retinal Screening Intervals Recommended
Three-year screening intervals can be recommended in those with mild type 2 diabetes and no retinopathy
This article is older than one year and is no longer available.

Copyright © 2011 HealthDay. All rights reserved.

March 26, 2015

Archive Search

By Keyword:
By Category:
By Topic:

Related Articles

Greater Use of Antibiotics Tied to Higher Odds of Diabetes

FDA: Eylea Approval Expanded to Include Diabetic Retinopathy

Newly Identified Diabetes Up With Medicaid Expansion

Electronic Solutions Underway for Rx Prior Authorizations

More Than 16 Million Americans Have Gained Coverage Under ACA

Gender-Specific Variation in Medical Specialties